Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs. Remifentanil for Sedation in Cataract Surgery
NCT03401606Phase 4Terminated
- Sponsor
- Fundación Universitaria de Ciencias de la Salud
- Start
- Nov 2014
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of dexmedetomidine, remifentanil, sponsored by Fundación Universitaria de Ciencias de la Salud. Started Nov 2014; status: terminated.
02
Drugs
dexmedetomidineremifentanil
Beyond the preview
Go deeper on NCT03401606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401606.